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ABSTRACT
Nanoparticles (NPs) have a huge interest for transdermal applications,
demonstrating their ability to be trapped in the hair follicles (HFs) where they release
the entrapped compounds. For hair cosmetics, this discovery is particularly important
as it can improve the treatment of several hair follicle related disorders/diseases.
Therefore, the aim of this work was to obtain NPs of Poly (Lactic Acid) (PLA-NPs) for
topical delivery of drugs at the level of the HFs. Further, these particles may be used
for cosmetic applications in human hair.
The effect of several parameters was examined, in order to establish an
improved nanoprecipitation protocol for the preparation of suitable PLA carriers for
follicular targeting. Thus, the application of mechanical stirring or ultrasound, the use
of Acetone/Ethanol (50/50, v/v) as the solvent phase and the addition of 0.6% (w/w) of
Pluronic F68 to the formulation showed the best compromise between the desired
properties (monodispersed populations of particles with a mean size of ≈150 nm were 
obtained, the ζ-potential was less than -18 mV and particles exhibited a spherical 
shape with smooth surface) and the yield of nanoparticles (≈90% was showed for 
particles produced with agitation and ≈70% when ultrasound was employed). 
After the encapsulation of model compounds, no significant changes were
found in the properties of particles and the entrapment efficiency was above 80%.
Nevertheless, the use of sonication promoted higher loading efficiencies. In turn, the
release kinetics of PLA nanoparticles indicated an anomalous dye transport mechanism
(diffusion and polymer degradation) for Nile Red (lipophilic) and a Fickian diffusion of
first order for FITC (hydrophilic). Furthermore, the release from particles produced
with agitation was slightly faster than from particles produced with sonication.
Finally, fluorescence microscopy on porcine skin cryosections showed that the
produced PLA-NPs can effectively transport lipophilic and hydrophilic compounds into
the HFs, with fluorochromes reaching a maximal depth corresponding to the full
follicles length after 24h.
In conclusion, the modified nanoprecipitation protocol presented in this study
allows the preparation of PLA nanocarriers with potential for hair follicle therapy and
the yields obtained are acceptable for industrial purposes.
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RESUMO
As nanopartículas (NPs) são de grande interesse para aplicações
transdérmicas, acumulando-se nos folículos capilares (FC) onde libertam os compostos
encapsulados. Esta descoberta é particularmente importante para a cosmética capilar,
podendo melhorar o tratamento de várias doenças/distúrbios associados aos FC.
Consequentemente, este trabalho visou a obtenção de NPs de Poli (Ácido Lático) (PAL-
NPs) para entrega de agentes terapêuticos ao nível dos FC. No futuro, estas partículas
poderão ser utilizadas para aplicações cosméticas em cabelo humano.
Inicialmente, o efeito de algumas variáveis experimentais foi testado, de
modo a melhorar o protocolo de nanoprecipitação para a produção de PAL-NPs aptas
para entrega de princípios ativos ao nível dos FC. Assim, a melhor relação entre as
propriedades desejadas e o rendimento em nanopartículas foi obtida com a aplicação
de agitação mecânica ou ultrassons, o uso de Acetona/Etanol (50/50, v/v) como fase
solvente e a adição de 0.6% (w/w) de Pluronic F68 à formulação. Com estas condições
obtiveram-se populações monodispersas de partículas esféricas com uma superfície
lisa, tamanhos médios de 150 nm, carga superficial inferior a -18 mV e rendimentos de
≈90% e ≈70% para partículas produzidas com agitação e sonicação, respetivamente. 
Após um encapsulamento eficiente (> 80%) do Nile Red e do FITC, não foram
registadas alterações significativas nas propriedades das partículas. Por sua vez, o
mecanismo de libertação dos compostos mostrou-se dependente da sua natureza:
para o Nile Red (lipofílico) ocorreu transporte anómalo (difusão e degradação do
polímero) e a libertação do FITC (hidrofílico) foi controlada por difusão fickiana de
primeira ordem. É também de salientar que a libertação dos fluorocromos foi
ligeiramente mais rápida para partículas produzidas com agitação.
Por último, usando microscopia de fluorescência em secções de pele de
porco, provou-se que as NPs produzidas são eficazes no transporte de compostos
lipofílicos e hidrofílicos para o interior dos FC. Mais ainda, ao fim de 24h foi possível
detetar a presença dos corantes ao longo de toda a extensão destas estruturas.
Em suma, as alterações introduzidas ao protocolo de nanoprecipitação
permitiram a preparação de nanopartículas de PAL com potencial para terapia folicular
sendo que, os rendimentos obtidos são aceitáveis para aplicação industrial.
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Nanotechnology is an interdisciplinary area that deals with the development,
manipulation and control of materials at nanometric scale, in order to take advantage
of their singular physical, chemical and biological properties [1, 2]. Currently, due to
the many new options that this scale can offer, nanotechnology is a key field of
research, providing means for achieving otherwise unreachable goals [3, 4].
The cosmetic industry was among the first to use nanotechnology in the
development of products. From 1994 to 2005, L’Oreal SA (France) was worldwide
ranked in 5th placed on the total number of nanotechnology-based products and in
2009, more than 13% of nanostructured products available in the market were
classified for cosmetic use [4]. This growing interest in the development of
nanotechnological cosmetics occurred because nanomaterials have the potential to
radically change the way cosmetics deliver their benefits, leading to product
innovation, which consequently may stimulate the economy of one of the most
important worldwide industries [5, 6].
Among nanomaterials for cosmetic use, nanoparticles (NPs) are of particular
interest because they improve the stability of various cosmetic ingredients like
unsaturated fatty acids, enhance the penetration of certain agents as vitamin and
other oxidants, increase the efficacy and tolerance of UV filters on the skin surface and
make the product more aesthetically pleasing [7]. Moreover, NPs are also important
for cosmetic applications because they can encapsulate a wide range of ingredients as
vitamins, fragrances, and drugs with cosmetic or dermatological purposes and act as
Drug Delivery Systems (DDS) [5].
Regarding to the route of administration, for cosmetic applications but not
only, the transport of DDS through the skin has been widely studied because it offers
numerous advantages over other routes [8]. After topical application, although
nanoparticles may accumulate at different skin sites depending on their properties,
they tend to be trapped inside the hair follicles (HFs), reaching high concentrations at
these sites [9]. This localized accumulation of nanoparticles is very important for hair
cosmetics because, using NPs it will be possible to achieve adequate concentrations of
active ingredients into these structures, in order to treat many hair follicle related
disorders/diseases without damages to the hair or skin lesions [10].
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The present study aimed to obtain nanoparticles that could be used as
carriers for topical delivery of drugs at the level of the HFs. Thus, these particles may
be used for cosmetic applications in human hair. Initially, to achieve the ultimate goal
proposed, the influence of several experimental factors was tested in order to obtain
an adequate formulation for the production of Poly (D,L-Lactic Acid) nanoparticles
(PLA-NPs) by nanoprecipitation methodology. The yield of nanoparticles was further
determined and the entrapment efficiency and release profile of hydrophilic and
lipophilic compounds from PLA-NPs were achieved. Finally, the ability of these
particles to penetrate the skin and accumulate in the HFs was assessed in vitro.
2. REVIEW OF THE LITERATURE
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2.1. Nanoparticles as Carriers for Drug Delivery
In the last decades, significant advances have been made in the production of
nanoparticles (NPs) as carriers to deliver therapeutic agents into the body [11]. Thus,
the application of nanotechnology on drug delivery enabled the creation of entirely
new therapeutic agents [12].
The main advantage of NPs as drug delivery systems (DDS) is their ability to
target specific cell populations in the human body and to help in the intracellular
uptake of the drugs [13]. The efficiency of drug delivery to various parts of the body is
directly affected by particle size but it can be modulated through the modification of
particle surface (e.g., binding to specific ligands as monoclonal antibodies to target a
selected cell population) [11]. By providing a high local concentration just at the
desired site of action, NPs enhance the bioavailability of drugs, minimizing the amount
of active substances needed. The application of a low dose of drugs reduces the risk of
side-effects in other tissues and it makes possible to use certain drugs that were
previously impractical because of their toxicities [11, 13, 14]. Another important
feature of NPs is their capacity to promote a sustained drug release over a prolonged
period of time [11]. Controlling the drug carrier architecture (e.g., porosity), the
release of the drug can be tuned to achieve a desired kinetic profile, fixating the
concentration of the encapsulated substance between the Minimum Effective
Concentration (MEC) and the Minimum Toxic Concentration (MTC), for an adequate
period of time (Figure 2-1); achieving a constant drug level in tissues, the therapeutic
index (ratio between the efficacy of the drug and its undesirable side effects) is
maximized [11, 13, 15]. In conventional systems, many applications are need to
maintain the drug level above MEC (otherwise there is no beneficial effect) and bellow
MTC (above this limit, the active substance becomes toxic) because, following a
relatively short period at the therapeutic level, drug concentration drops off until re-
administration [15, 16]. Thus, NPs can reduce the frequency of drug administration,
increasing the consumer’s compliance and acceptance [11]. Finally, nanoparticles can
also provide protection to the encapsulated drugs, making them more stables,
resulting in the maintenance of their bioactivity until they reach the target [17, 18].
Preparation of Particles for Cosmetic Applications in Human Hair
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solvent by the polar heads (normal micelle) or else an aqueous core separated by the
polar heads from a fatty solvent (inverse micelle) [3]. SLNs are formed by a matrix of
lipids which are biodegradable raw materials that are physiological well tolerated [22].
Dendrimers, a unique class of polymers, are highly branched macromolecules whose
size and shape can be precisely controlled [13]. Finally, polymeric nanoparticles have a
core surrounded by a polymeric shell and generally, they exhibit greater stability [23].
While there is plenty of research in the production of nanoparticles for drug delivery,
only a few of them have reached the market because they are still several limitations
associated with the design and characterization of these materials (ability to
reproducibly fabricate speciﬁc nanoparticle shapes and sizes, to achieve optimal drug 
loading of carrier, to control drug release and delivery and to design stable materials,
which do not release harmful degradation products) [14, 24]. The initial cost of
materials and the expensive processes also has limited the commercial distribution of
these systems [15]. However, the remarkable results achieved with nanoparticulate
DSS in animal models are promising for their extensive commercialization in the
coming years [11].
The administration of nanoparticulate DSS to humans can be made through
injection or across oral, pulmonary, ocular, transmucosal and dermal routes [13].
Lately, special attention has been given to the transport of drugs through the skin
(topical application), because this route offers a lot of vantages when compared, for
example, to intravenous injection or oral administration [8]. The administration of
nanoparticles through the skin is particularly important in the field of cosmetic, once
those particles had proved to be valuable for optimizing current galenical formulations
for topical dermatotherapy [11].
2.2. Drug Administration through the Skin
The main function of the skin is to provide a protective barrier against
external agents; however, its passive diffusion mechanism can also allow the
penetration of substances, making it a potential route for the delivery of drugs into the
Preparation of Particles for Cosmetic Applications in Human Hair
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body [25, 26]. According to the purpose, the delivery through the skin can be divided
into topical and transdermal delivery; topical delivery involves drug administration for
local therapeutic effects, whereas transdermal delivery uses the skin as a route for the
transport of drugs into the circulatory system [27].
The skin offers many advantages over other routes of drug administration
because it is a large and readily accessible surface area for absorption, the application
is a noninvasive procedure (allowing continuous intervention) and it is possible to
cease the absorption preventing overdose or undesirable effects [28]. When compared
with the traditional oral route of drug administration, additional advantages are
shown: it avoids the gastrointestinal tract (and consequently, drug degradation under
the extreme acidity of the stomach), it avoids hepatic first pass metabolism (increasing
the bioavailability of drug) and it reduces the fluctuations on the drugs level in the
plasma, minimizing the risk of systemic side effects [25, 28]. Despite all the advantages
of drug administration through the skin, this route also has some disadvantages such
as, higher molecular weight candidates fail to penetrate without modifying the nature
of skin, drugs with very low or high partition coefficient fail to reach systemic
circulation and high melting drugs have difficult to permeate due to their low solubility
in the skin [25]. Therefore, to make these compounds suitable for topical
administration is necessary to increase skin permeability or increase solubility of drugs
in the skin [28].
2.2.1. Approaches to Overcoming the Dermal Barrier
Chemical and physical methods have been aimed to disrupt or weaken the
skin in an attempt to enhance drug transport across it [29]. Physical enhancement
methods usually involve the use of an energy source to overcome the barrier
properties of the skin and include iontophoresis (driving charged molecules into the
skin by a small direct current), electroporation (application of short micro- to milli-
second electrical pulses to create transient pores in skin) and sonophoresis (cavitation
caused by low frequency ultrasound energy, which increases skin fluidity) [28, 30, 31].
Review of the Literature
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Alternative physical approaches to increase skin permeability, without the use of an
energy source, involves the use of microneedles (which can be inserted into the skin
producing a channel for drug transport), jet-propelled particles (high-velocity jet of
compressed gas carrying drug particles) and ablation of the stratum corneum [30, 31].
For chemical enhancing of percutaneous absorption, water is the safest and most
widely used penetration enhancer; the increasing of hydration leads to a diminished
resistance of the skin [25]. Other chemical enhancers, which promote changes in the
structure of skin, have also been reported [32]. These chemicals can disrupt the lipid
organization of skin (e.g., azone, terpenes, fatty acids, dimethyl sulfoxide (DMSO) and
alcohols) or alter its protein organization (DMSO or urea) [28]. Although these
methods have proved to be effective for increase skin permeability to drugs, they also
induce irritation and they cause damages to the skin, reducing its barrier function [32].
2.2.2. Nanotechnology for Conquering the Skin Barrier
Since an ideal penetration enhancer should reversibly reduce the barrier
resistance of skin without damaging it, nanoparticulate DSS are the most promising
alternative to the physical and chemical penetration enhancer systems [14, 32, 33].
Nanoparticles can modify the physicochemical properties of the encapsulated
molecules and offer a means to facilitate the percutaneous delivery of substances,
increasing the permeability and transport of therapeutic agents into/across the skin
without damaging it [14, 26, 32, 33]. NPs can also protect drugs from be metabolized
by mircoflora or enzymes on the surface of skin and prevent allergic responses in skin
induced by the encapsulated drugs [25].
Despite the advances in recent years, the transport of a wide range of drugs
through the skin is still limited due to the special composition and structure of skin,
which provides a formidable barrier to penetration [25, 31, 34]. Thus, explore and
understanding the anatomy, physiology and chemical composition of the skin is
important to improve the nanoparticles design and increase the ability to deliver these
materials with wide systemic and topical application [14, 28]. An understanding of the
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interactions between these novel drug delivery systems and the skin, as well as the
transport pathways within the skin, is also required to establish the feasibility of using
nanoparticles to optimize the transport process [33].
2.3. The Dermal Barrier
The skin, or cutis, is considered the largest human organ; being normally less
than 2 mm thin, it accounts more than 10% of the body mass and have an average
surface of approximately 2 m2. This organ enables the body to interact dynamically
with the environment and plays many functions (protective, homeostatic and
sensorial), essential for the survival of the human beings [35]. Specifically, the excellent
protective/biological barrier function of skin protects the body against external
mechanical, chemical, microbial and physical influences [3]. To maintain its
characteristics, this organ is in a continual renewing process [28].
Because of large surface area and easy accessibility, skin delivery has potential
application in drug delivery [36]. However, the functional properties that enable skin
to act as an excellent barrier also serve to limit the access of drugs into and across it
[28]. Whereas an initial consideration of the skin structure might suggest a simple
barrier, a closer examination reveals a complex combination of a range of cell types
[31]. Thus, to optimize the delivery of drugs into or across the skin is important to
learn its structure, in order to learn how to overcoming its barrier function [37].
2.3.1. The Structure of the Skin
The Figure 2-2 shows the structure of the skin. Anatomically, it is composed of
epidermis, dermis and hypodermis (also called subcutaneous tissue), being a complex
barrier as a consequence of its anatomical organization and special chemical
composition [22, 27]. In addition to these main layers, several pilosebaceous units (hair
follicles and associated sebaceous glands) and apocrine or eccrine sweat glands are
Review of the Literature
dispersed throughout the skin [14, 36]. Owing to its unique biochemical and
anatomical properties, each individual skin layer is mechanically different [3].
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protein) embedded in a semigel matrix, which contains water, ions and
mucopolysaccharides; this matrix allows the oxygen and nutrients to diffuse to the
epidermal cells [37]. The dermis shelters a network of blood capillaries, lymphatic
vessels, nerve endings and nearly all elastic ﬁbers giving mechanical stability to the skin 
[36]. Finally, this region of skin contains only few cells, predominantly ﬁbroblasts 
(responsible for the connective tissue synthesis), mast cells (involved in the immune
and inflammatory responses) and melanocytes (involved in the production of melanin)
[37].
The top layer of the skin (epidermis) is typically 50-150 μm thin and it contains 
four histologically distinct strata of keratinocytes, which varying in the differentiation
level [3, 37]. The innermost Stratum Basale is composed of two keratinocyte types,
one that acts as stem cells having a proliferation capacity, and the second one which
serves as anchor to the basement membrane; in this strata is also possible to find
Merkel cells (sensory perception), Langerhans cells (immunological function) and
melanocytes (melanin production) [14, 36]. During the differentiation process to form
the higher epidermal layers, keratinocytes undergo a process of keratinization, in
which the cell differentiates and moves upward from Stratum Basale, through the
Stratum Spinosum and Stratum Granulosum, to the outermost layer, the Stratum
Corneum (SC), also called horny layer or non-viable epidermis [14]. Therefore, the SC
represents the final stage of epidermal cell differentiation and it has an approximately
thickness of 5 - 20 µm but a number of factors, including the degree of hydration and
skin location, can influence it [29, 37]. This layer is the main responsible for the
resilient absorption properties of skin, providing protection to the body against the
entry of external materials but it is also the main barrier for diffusion of water out of
the skin [14, 27, 36].
2.3.1.1. Organization of the Stratum Corneum
The structure of SC has been described by “brick and mortar” model (Figure 2-
3) and it was first presented by Michaels et al. [38].
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Figure 2-3: Schematic representation of the “brick and mortar” model of the
stratum corneum (Adapted from Moghimi H.R. et al, 1996 [39]).
The “bricks” of the model correspond to hydrophilic corneocytes (also called
horny cells) which are dead, anuclear, flattened and hexagonal cells [14, 27, 28]. They
are composed mainly of insoluble bundled keratins (70%) and lipids (approx. 20%);
their approximate diameter and thickness is 40 µm and 0.5 µm, respectively [28, 37].
In SC, corneocytes are vertically stacked into columns (perpendicular to the skin
surface) and each column contains between 10 and 15 cellular layers of keratinized
cells. The “bricks” are joined together by desmosomes, which help to form a tough
outer layer by maintaining cellular shape and regular packing [14, 28]. The inter-
cellular space in SC is usually less than 100 nm thick except at cell clusters junctions, in
the 2 to 3 partly detached cellular layers close to skin surface (where corneocytes are
less densely packed or even partially detached) and at the 2 to 3 layers at the bottom
of SC where the terminal cells differentiation has only just begun [3].
In the model, the “mortar” represents the hydrophobic continuous matrix of
lipids in which the corneocytes are embedded; this lipid matrix provides the only
continuous diffusion pathway from the skin surface to the base of the SC [27, 37]. The
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main lipids in the intercellular spaces of SC are ceramides, fatty acids, cholesterol,
cholesterol sulphate and sterol/wax esters; unlike almost all other membranes in the
body, the phospholipids in SC are largely absent. Ceramides are the largest group of
lipids and its compact stacking is the primary determinant of the extremely stable
physical properties of the SC [27]. According to Landmann model, the intercellular lipid
matrix is generated by keratinocytes in the mid to upper part of the Stratum
Granulosum, discharging their lamellar contents into the intercellular space [40]. In the
initial layers of the SC, this extruded material rearranges to form broad intercellular
lipid lamellae which then associate into multiple lipid bilayers, parallel to the surface of
SC [31]. The hydrocarbon chains became arranged into regions of crystalline, lamellar
gel and lamellar liquid crystal phases, thereby creating various domains within the lipid
bilayers; it has been proposed that the distribution of crystalline and gel phases of the
membrane lipids influences the diffusion of small molecules across the SC and into the
dermis. [33, 38] Between the lipid bilayers, there are layers of water [28]. Water is an
essential component, because it acts as a plasticizer to prevent cracking of the SC;
some of extra water in maximally hydrated SC is sequestered into these layers, so-
called “lacunae” [3, 31].
At the surface of SC, there is also an irregular and discontinuous layer (0.4–10
µm) consisting of sebum secreted by the sebaceous glands, along with sweat, bacteria
and dead skin cells. However, this layer is considered to have a negligible effect as an
additional barrier to permeation through the SC [14].
2.3.1.1.1. Transport Routes across the Stratum Corneum
Despite the composition and structure of the SC offers a main obstacle and a
real challenge on drug delivery into and through the skin, its “brick and mortar”
organization also provides some possible pathways to the passive diffusion of
substances into the skin, as schematized in Figure 2-4. These pathways are through the
keratinocytes (intracellular pathway), through the lipid matrix occupying the spaces
between the keratinocytes (intercellular pathway) and across hair follicles, sebaceous
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glands and sweat glands (transappendageal pathway) [14, 36]. However, the transport
pathway is highly influenced by the structure, size and solubility of the penetrant [27].
Thus, understanding the physicochemical properties of the penetrant is essential to
determine the predominant route of drug permeation and thereby optimize its
delivery [31].
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influences the absorption through this pathway, because penetrants need to fit into
the intercellular space in order to move along it [21].
The hydrophilic entities have therefore, the propensity to cross normal skin
within the aqueous regions near the outer surface of corneocytes or through
corneocytes, along the most curved cell plasma membranes - intracellular pathway [3].
However, in this route, not only the drug must partition into and diffuse through the
corneocyte but also, in order to move to the next corneocyte, the permeant must
partioning into and diffuse through the lipid lamellae between corneocytes [31].
Until recently, the transappendageal pathway was barely considered as a
penetration pathway because it covers only 0.1% of the skin surface area.
Nevertheless, this route became to receive considerable attention once it provides an
efficient penetration pathway and more important, it was realized that the
appendages can act as reservoirs of topically applied substances [43, 44]. Among the
appendages, the hair follicles (HFs) are of particular interest because they seem to be
the preferential targets for nanoparticles [21, 43]. This favored penetration of
nanoparticles through the HFs and their reservoir function for topically applied
substances has the potential to revolutionize the treatment of hair follicle associated
diseases (e.g., acne and some skin cancers) and the treatment of many
diseases/disorders of human hair (e.g. hirsutism, graying, alopecia) that have dramatic
effects on the appearance, socio-cultural status and self-esteem of the affected
individuals [10, 45, 46].
2.4. The Follicular Pathway
Even though the HFs are increasingly recognized as a potentially route for the
entrance of topical applied substances into the skin, the invasion of a substance into
these structures is not an absorption process itself because, by definition, the
compounds inside these appendages are still on the outside of the body [31].
However, since HFs are invaginations of the epidermis extending into the dermis, they
provide a much greater actual area for absorption bellow the skin surface [47]. Also, as
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it extend into the hair follicles, the surrounding SC layer is progressively reduced,
which may lead to a faster and more efficient diffusion of solutes from out of the
follicles to the inside of the skin; the dense network of blood capillaries at the lower
levels of the HFs also facilitates the uptake of topically applied substances [14, 31].
Another feature of the HFs that makes them interesting for topical delivery is their
reservoir function [41]. While the reservoir of the SC is located in the uppermost cell
layers of the horny layer (approximately 5 μm), the reservoir of the HFs is usually 
extended deep in the tissue up to 2000 μm [48]. 
Even if the HFs are potential routes for the absorption of topically applied
substances, not all hair follicles are available for penetration and they have to be
distinguished between “open” and “closed” [49]. The hair follicles “open” to
penetration exhibit hair growth and/or sebum production which act as a pumping
system, pushing topically applied substances mechanically into the hair follicles when
the hairs are in motion [50]. This was kind of surprising as the direction of hair growth
and sebum flow are opposed to the invasion of materials into the follicles, suggesting
an “active” uptake mechanism transporting them deep into the follicle [48]. In the
“open” hair follicles, the release of sebum also influences the absorption and, since
sebum consist mostly neutral, non-polar lipids, it provides a lipoidal pathway that it
will favor the penetration of more lipophilic permeants [26, 47]. Depending on the skin
samples, approximately 50-70% of hair follicles are open for penetration [36].
2.4.1. Anatomy of the Hair Follicles
In order to develop appropriated studies of follicular delivery, an
understanding of the structure of the HFs is useful. The hair follicle, represented in
Figure 2-5, is composed of a hair bulb and a hair shaft [46, 47]. The hair bulb, localized
at the base of the hair follicle, encloses a small papilla of dermis, which it is a structure
of actively growing cells that produce the long fine cylinder of a hair [51]. The dermal
papilla is connected to the blood vessels, an important feature when the HFs are used
as route for transport of drugs into the systemic circulation [47, 52]. The hair bulb and
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shaft are enveloped in an inner root sheath and an outer root sheath [52]. The outer
root sheath is a stratiﬁed epithelium that is continuous with the epidermis and this 
continuity is responsible for the increased surface area of absorption beneath the
surface of the skin, making of this layer the most important with regard to drug
delivery [47]. On the contrary to the outer root sheath, the inner root sheath ends
about halfway up the follicle [46].
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muscle, is called pilosebaceous unit; usually, the terms hair follicle and pilosebaceous
unit are used interchangeably [52].
The hair follicle (or pilosebaceous unit) can be divided into four parts: the
infundibulum (zone between the skin surface and the point where the sebaceous gland
duct opening into the follicle canal), the isthmus (between the sebaceous gland duct
opening and the bulge region), the suprabulbar zone (between the bulge area and the
hair bulb) and the hair bulb. The lower part of the infundibulum, called
infrainfundibulum, may experience a continuous loss of epidermal differentiation
occurring towards the isthmus and creating the major entry point for applied
substances [52]. As the hair follicles are composed of many structures and have several
zones with different populations of cells, they offer a lot of therapeutic targets for the
treatment of disorders of human hair and hair follicle associated diseases [53].
2.4.1.1. Target Structures for Follicular Therapy
At the HFs, the major target areas for drug delivery are the sebaceous glands,
the bulge region and the hair bulb (Figure 2-5) [54]. The sebaceous glands represent an
important therapeutic site because they are implicated in the aetiology of
androgenetic alopecia (with the clinical consequence of increased hair loss) and acne,
as well as other sebaceous gland dysfunctions [10, 49]. Along with the sebaceous
glands, the bulge region is the most important target site within the hair follicle. Since
the bulge region is the host of epithelial stem cells with high proliferative capacity and
multipotency (which make them capable to repopulate hair follicles, sebaceous glands
and epidermis), it opened new directions for their utilization in hair and skin
regenerative medicine [10]. The gene delivery to stem cells of the bulge region can
facilitate long-term gene correction of congenital hair disorders (hair loss or hair
overgrowth) or genetic skin disorders; however, for this purpose, profound knowledge
of genes and signaling pathways involved in hair diseases are necessary, in order to
allow specific modulation using, for example, RNA interference [10, 49, 52]. The
localization of melanocytes stem cells at this region also offers the opportunity to treat
Preparation of Particles for Cosmetic Applications in Human Hair
22
pigmentation disorders [47]. Another desirable target in hair follicle is the hair bulb,
where matrix cells and melanocytes can be found [11]. Such as epithelial and
melanocyte stem cells of hair bulge, the hair matrix cells and melanocytes (involved in
the production of melanin through melanogenesis) of hair bulb are also responsible for
follicle reconstitution (playing an important role in the control of hair growth) and
pigmentation, respectively [10, 52].
2.5. Nanoparticles for Hair Follicle Therapy
As mentioned before, when applied topically, nanoparticles have tendency to
accumulate preferentially in the hair follicle orifices (see section about “Transport
Routes across the Stratum Corneum”); on the other hand, free drugs can enter the skin
through the stratum corneum and the hair follicles, indistinctly. When the hair therapy
is intended, the loading of therapeutic agents into nanoparticles is important because
it reduces the penetration of drugs through the trans-epidermal pathway, increasing
their concentration in the hair follicle [31]. The use of nanoparticles for hair therapy is
also favorable because, it is known that drugs penetrate better into hair follicles when
they are inside the particles [49]. However, the penetration of nanoparticles within the
follicular duct is dependent of their diameter, with smaller particles showing increased
penetration depths [11]. This particularity is also significant for hair therapy, since the
targets for drug delivery are found at different depths of the follicle (Figure 2-5). Thus,
it is possible to reach a specific site of action (located at a certain depth) by controlling
the size of the applied particles [52]. Once inside the follicles, the storage time of
nanoparticles is longer, when compared to short-time storage in SC. This happens
because the depletion of stored nanoparticles from follicular reservoir is dependent of
slow processes as penetration of particles into deeper tissue layers or by their release
with the outflow of sebum [36, 55]. The long time storage of nanoparticles within the
follicle canal ensures a prolonged drug release, which enables the reduction of the
applied dose as well as the frequency of application [31].
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Since the follicular pathway favors the penetration of lipophilic rather than
hydrophilic drug carriers (see section about “The Follicular Pathway”), many kinds of
lipophilic particles have been investigated for follicular target and drug delivery upon
topical application [45, 52]. Among them, lipophilic polymeric nanoparticles are the
most promising technology and they have shown many advantages over other
systems. Polymeric particles helps to mask the intrinsic properties of encapsulated
drugs, which can facilitate the entrance of therapeutic agents that otherwise have low
solubility on the sebum (e.g., hydrophilic substances) [22, 37].
2.5.1. Polymeric Nanoparticles
Polymeric nanoparticles can be synthetized from synthetic and natural
polymers, varying in polarity from hydrophilic to hydrophobic [56]. However, natural
polymers as proteins and polysaccharides are not extensively used because they vary
in purity and often require preparation processes that can lead to drug degradation
[37]. Concerning to the synthetic ones, the accumulation and the potential cytotoxicity
of non-biodegradable polymers is a major problem and limits their use in humans.
Therefore, just a few types of biocompatible and biodegradable polyesters like poly
(lactic acid) (PLA), poly lactic-co-glycolic acid (PLGA) and poly-ε-caprolactone (PCL) 
have been widely studied [11, 57]. Among these polyesters, in the preparation of
polymeric drug delivery systems for long-term sustained-release of various drugs, PLA
has numerous advantages over the others because, it is produced from renewable
resources, it is recyclable and compostable, its physical and mechanical properties can
be easily altered though the manipulation of its architecture and it is approved by Food
and Drug Administration (FDA) for clinic use [58, 59].
PLA (Figure 2-6) is a linear, lipophilic, thermoplastic, high-strength and high-
modulus polymer, soluble in organic solvents but insoluble in common alcohols and
water [11, 18, 60]. Its constituting monomer is lactic acid, obtained annually from
renewable resources such as corn starch or sugarcane, by carbohydrate fermentation
[11, 60]. Lactic acid exists in two optically active configurations, L- lactic acid and D-
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lactic acid and, polymers synthesized from one of them are partially crystalline while
the racemic poly (D, L-lactic acid) is amorphous [18].
Figure 2-6: Chain structure of PLA (Online image, available at
http://www.medicinescomplete.com/mc/excipients/current/images/
Ecpoly_dl_lactic_acidC001_default.png; accessed on September 10,
2012).
The synthesis of PLA can follow two different routes of polymerization:
condensation/coupling and ring-open polymerization [60]. The first route leads to the
formation of a polymer by the linking of monomers with the release of water or similar
simple substances, allowing the production of low molecular weight PLAs (<
3000 g/mol). On the other hand, ring-opening polymerization produces polymers with
higher molecular weights and the method is based in addition polymerization where
the terminal end of a polymer acts as a reactive center and cyclic monomers join to
form a larger polymer chain [18, 59].
The presence of ester linkages in the polymer backbone allows its hydrolytic
degradation in aqueous environment. The degradation rate is dependent on several
parameters such as crystallinity (crystalline PLA degrades slower), molecular weight
(low molecular weight PLAs degrade faster) and the environment conditions (pH, ionic
strength, temperature) [18]. Regarding to the production of drug delivery systems,
these dependence between the properties of polymer and its degradation rate is an
important advantage of PLA; since the degradation rate is related to the release of
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drugs, altering the polymeric material, it is possible to manufacture systems with a rate
delivery that can be modulated depending on duration of the desired effect [61].
Following the hydrolysis of the polymer, the only degradation product is lactic acid,
which it is biocompatible, metabolized through citric acid cycle and then removed from
the body [18].
2.5.1.1. Preparation of Drug-loaded Polymeric Nanoparticles
Numerous methods such as single emulsion [62], spontaneous emulsion
solvent diffusion (SESD) [63], double emulsion [23], salting-out [64], spray drying [65]
and nanoprecipitation [66] have been proposed for the preparation of polymeric drug-
loaded nanoparticles. All of these methods are able to produce NPs with high yield and
high encapsulation efficiency and, in general, the process is critical in determining
nanoparticle size [67, 68]. Considering the encapsulation mechanism, the drugs can be
entrapped, dispersed, dissolved within or simply adsorbed on the matrix of
nanoparticles (Figure 2-7), depending upon the method of preparation and the
physico-chemical properties of the therapeutic agent [22].
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The great challenge in choosing a method for the preparation of particles
consists on an adequate formulation, establishing the ideal amounts of drug, polymer,
solvent and non-solvent, which it will allow the production of stable nanoparticles,
efficient entrapment of drugs and their release according to the desirable profile [15,
67].
In the production of polymeric particles with single emulsion method (also
known as solvent evaporation method), Figure 2-8, the polymer is dissolved in an
organic solvent along with the drug and this mixture is emulsified into an aqueous
solution, using a surfactant/emulsifying agent. After formation of stable oil in water
(o/w) emulsion, the organic solvent is evaporated from dispersed oil droplets
(containing both polymer and drug) [62].
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and emulsion droplets are formed; droplets can also be induced by sonication and
homogenization [57, 69]. Due to the quickly spontaneous diffusion of water-soluble
solvent out from each emulsion, an interfacial turbulence between the two phases is
created and a drastically reduction in the size of particles is obtained (Figure 2-9) [15,
62]. The consequent removal of the organic solvent from the system makes the
droplets solidify to finally form polymeric nanoparticles varying in size from 100 to
400 nm. However, a major concern about this method is the large-scale production
that sometimes causes a severe aggregation in the particle formation when the
polymeric concentration is increased to an acceptable range for industrial purposes
[57].
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the degradable polymer - the first emulsion, water in oil (w/o), is formed. Then, the
w/o emulsion is dispersed into an aqueous medium (containing a stabilizer), forming
the final w/o/w emulsion. Once again, as the solvent evaporates, the polymer hardens
encapsulating the drug [16].
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A preparation technique that it is suitable for industrial scalable processing is
spray drying because it is very rapid and convenient, also having very few processing
parameters. In this process, drug-loaded particles are prepared by spraying a solid-in-
oil dispersion or water-in-oil emulsion in a stream of heated air. The type of drug
(hydrophobic or hydrophilic) decides the choice of solvent to be used in the process
[65].
The nanoprecipitation, first introduced by Fessi et al., is the most commonly
used technique to formulate polymeric nanoparticles, intended for cutaneous
applications [22, 66]. It is a simple, fast, efficient, economic and reproducible method
for the preparation of small particles, based on precipitation and subsequent
solidification of the polymer at the interface of a solvent and a non-solvent (Figure 2-
11). Thus, the process is often called solvent displacement or interfacial deposition.
[18, 22, 68] The choice of the polymer, solvent and non-solvent system is critical for
the success of the method and the nature of the polymer-solvent interactions has
been reported to affect the properties of the nanoparticle preparation. However, no
clear guidelines about the influence of each of the three components of the system
have yet emerged [68].
Figure 2-11: Schematic illustration of the nanoprecipitation method (Adapted from
Gomes V.M.A., 2009 [15]).
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To achieve nanoprecipitation, the polymer is dissolved in an organic solvent
(or mixture of solvents) and added to a non-solvent of the polymer wherewith the
organic solvent is miscible; depending on its solubility, the drug to be encapsulated
must be dispersed in the aqueous solution or dissolved in the organic solvent before
the fusion of the phases [18, 68]. The nanoparticles form instantaneously by
precipitation of the polymer and Marangoni effect is considered to explain the
process: solvent flow, diffusion and surface tension at the interface of the organic
solvent and the aqueous phase cause turbulences, which form small droplets
containing the polymer; subsequently, as the solvent diffuses out from the droplets,
the polymer precipitates. To finish, the organic solvent is typically removed by
evaporation [18, 68]. Although the presence of surfactants/stabilizers is not
indispensable for the formation of the particles, they can be included in the process to
modify the size and the surface properties or to ensure the stability of the nanoparticle
dispersion (especially during the early stages of the precipitation). Thus, in this
method, no emulsification step (which is usually part of a nanoparticle preparation
process), laborious processing conditions or special laboratory ware is needed and the
nanoparticles prepared by nanoprecipitation are typically smaller than 500 nm [18].
Nevertheless, this technique suffers the drawback of a poor encapsulation efficacy of
water-soluble drugs due to the rapid migration, and therefore loss of drug, into the
aqueous phase [70].
The methods previously mentioned can be successfully employed for the
encapsulation of many drugs as hinokitinol [71], minoxidil [72], latanoprost [73],
finasteride [74], cyclosporine A [75] and tamoxifen [76]. All of these therapeutic agents
have been studied and developed for the safe and effective treatment of several hair
follicle disorders/diseases.
2.5.1.2. Drug Release from Polymeric Nanoparticles
After the penetration of nanoparticles inside the hair follicle canal, the
encapsulated drug is released and, independently, it penetrates through the intact
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barrier of the hair follicle to reach the target structure (Figure 2-12) [50]. The rate of
release is dependent upon desorption of the surface-bound/adsorbed drug, diffusion
of drug through the polymer wall, nanoparticle matrix degradation or a combined
degradation/diffusion process [62]. In nanoparticulate DSS, the ideal release profile of
a therapeutic agent is a near zero-order profile, which establishes a more constant
flow of the bioactive agent out of the carrier, maintaining more appropriate steady
level of the drug at the site of delivery [13]. In the development of a drug carrier, in
order to achieve this steady release rate, it is important to know the properties of the
delivery system, the characteristics of the drug and the degree of polymer-drug
interaction because they can influence the release of the bioactive compound [23].
Figure 2-12: Release of the drug and targeting of follicular structures. A)
Accumulation of polymeric drug-loaded nanoparticles within the hair
follicle canal, at the level of the target structure. B) Release of the drug
from the particles and its penetration through the hair follicle barrier.
(Adapted from Papakostas D. et al., 2011 [11]).
Regarding to the properties of the carrier, a decrease in particle size (and
increase in the surface area) results in high release. Higher porosity, inducing a larger
inner surface, can increase the influx of the release medium into the particles and,
thereby, also facilitate the drug diffusion rate. In addition, specific properties of the
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polymer that constitutes the matrix, as crystallinity and molecular weight, can also
affect the release of the drug [77]. Polymers with more crystallinity have limited
flexibility since the ordered alignment of the polymer chains lower the free volume.
Thus, they form particle cores with high microviscosity that prevent the diffusion of
the drug and water molecules. In contrast, amorphous polymers tend to form cores
with lower microviscosity and a higher rate of diffusion [23]. Polymer with higher
molecular weight have lower degradation rates, because it requires more time to
degrade longer polymer chains than small polymer chains, and the release of drugs is
slower [65].
Concerning to the characteristics of the encapsulated drug, the amount of it
present in the particles influence the drug release kinetic and usually, an increasing in
the drug loading results in an increased rate of drug release. Conversely, an increase in
the molecular volume and molecular weight of the drug lead to a lower diffusion
coefficient and consequently, a lower release rate [23]. The entrapment of some
molecules as amines can interfere in the degradation mechanism of hydroxy acids
polymers (e.g., PLA), affecting the release rate [61].
Finally, the degree of polymer-drug compatibility also influences the rate of
drug release from the particles. When drugs are miscible with the polymer, and
consequently possesses good polymer-drug compatibility, there is an increase in the
extent of interaction between them that can slower the release of the drug [23].
2.6. Safety Aspects of Nanoparticles
Considering the enormous potential of nanotechnology-related products and
the prospect of mass commercialization in the coming years, namely for cosmetic
application, there is considerable concern regarding to the safety of manufactured
nanomaterials, as they may have characteristics different from their large-scale
counterparts [11, 17]. Accordingly, the risk assessments developed for ordinary
materials may be of limited use in determining the health and environmental risks of
nanotechnology products [17].
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Nanoparticles, because of their size, can get to places in the environment and
human body that are inaccessible to larger particles, and unusual or unexpected
exposures can occur. Since these particles also have larger surface-area-to-mass ratio
than bigger materials of the same composition and, as biological/chemical reactions
typically take place at the surface of materials, it has been hypothesized that
nanoparticles will be more reactive than bulk materials, undergoing dynamic
interactions with components of the environment with which they are in contact [17].
While this increased reactivity can be a useful attribute for nanomaterials, it also
carries potential risks and research looking into both particle-associated effects on
living organisms and particle alterations in their physico-chemical properties as a result
of particle-tissue interaction (which affect its behavior) is crucial and it must be
considered in conducting a risk assessment related to both human health and
environmental safety [11, 17].
Regarding to cosmetic applications, concerns have been raised about the
potential danger which may occur as a consequence of nanoparticle contact with
human skin. Thus, an advanced research is required to understand the behavior of
nanomaterials, including whether the nanoparticles remain on the surface of the skin
and/or in the outer dead layer (stratum corneum), the mechanism by which they
penetrate intact skin and how far a particle can penetrate the skin. For these studies, it
is important to know the physico-chemical characteristics of nanoparticles as size,
surface charge, specific surface area, porosity, water solubility, photocatalytic activity
and the potential for free radical formation. An understanding of how these properties
might affect the ability of nanoparticle to penetrate the skin would permit the
engineering of the nanomaterial to prevent it from either affecting skin cells or
possibly passing into the dermis and gaining access to the bloodstream [17].
About the toxicity of the nanoparticles for follicular targeting, these carriers
seems to be safe since they are mostly made of biodegradable and biocompatible
materials. Also, as long as their dimensions are larger than 100 nm, they are not able
to translocate into the viable epidermis of intact skin and, after some time (next to the
release of the bioactive agent) they are moved out of follicles because of sebum
production and excretion [45, 52]. However, there are still scarcely any studies focused
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on the long term fate of nanoparticles in the hair follicles, and this aspect definitely
needs investigation [52].
3. MATERIALS AND METHODS
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3.1. Materials and Equipment
3.1.1. Chemicals and Solvents
The chemical reagents used in this work were Poly (D,L-Lactic Acid) with a
molecular weight of 18000-24000 Da, Pluronic F68 (a non-ionic surface-active block co-
polymer also known as Poloxamer 188), Nile Red (318.4 Da, HPLC grade, purity ≥ 98%), 
Fluorescein 5(6)-isothiocyanate (398.4 Da, HPLC grade, approximately 90%), Methanol
(ACS reagent grade, ≥ 99.8%) and Isopropyl Myristate (Kosher grade, ≥ 98%). All of 
these chemicals were purchased from Sigma-Aldrich (Sigma Chemical Co., St. Louis,
MO). Acetone and Ethanol were of the highest grade commercially available and
purchase from several suppliers.
The storage of the reagents was done following the instructions of the
manufacturers and they were handled according to practices consistent with their
security information.
3.1.2. Porcine Skin Tissue
Full-thickness porcine skin (abdomen region) was obtained from Central
Carnes – Matadouro Central de Entre Douro e Minho, Lda. (Lousado, Portugal); skin
samples were excised on-site from freshly slaughtered pigs. The collection at the
slaughterhouse, as well as the handling of porcine skin tissue for purposes related to
scientific research, was approved by DGV-Direção Geral de Veterinária.
3.1.3. Equipment
Equipment used throughout the experimental work, their suppliers and the
methods associated with them are summarized in Table 3-1.
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Table 3-1: List of equipment, used in the course of this experimental work.
Equipment Method
20 kHz Vibracell™ CV 33 – Probe type
ultrasound source fitted with a 3 mm
diameter titanium micro-tip (Sonics
and Materials Inc., CT, USA)
Sonication
EmulsiFlex-C3 (Avestin, Ottawa,
Canada)
High Pressure Homogenization
ZetaSizer Nano ZS with ZetaSizer 6.01
software (Malvern Instruments Ltd,
Worcestershire, UK)
Photon Correlation Spectroscopy
(PCS); Laser Doppler Anemometry
(LDA)
NOVA™ Nano SEM 200 (FEI™, OR, USA) Scanning Transmission Electron
Microscopy (STEM)
SynergyMx with Gen5™ Microplate
Data Collector and Analysis Software
(Bio-Tek® Instruments, Inc., VT, USA)
UV-Vis Spectrophotometry
Diffusion Cell System V3A-02
(PermeGear Inc., PA, USA)
In vitro Follicular Penetration Studies
Leica CM1900 cryostat (Leica
Microsystems, Numsloch, Germany)
Cryosectioning
Leica DM 5000B Microscope with
DCF350FX Camera and AF6000
Modular Systems (Leica Microsystems
Numsloch, Germany)
Fluorescence Microscopy
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3.2. Methods
3.2.1. Preparation of PLA Nanoparticles
PLA nanoparticles were prepared based on the nanoprecipitation method
(also known as solvent displacement technique), originally described by Fessi et al. As
reported by these authors, the polymer was dissolved in an organic phase, acetone -
2% (w/w), and further added to an aqueous phase containing Pluronic F68. The
aqueous phase immediately turned milky with bluish opalescence due to the polymer
precipitation in the form of nanoparticles. The concentration of the surfactant in the
resultant solution was 0.6% (w/w) and the organic phase to aqueous phase ratio was
1:2. Finally, the solvent was completely removed under reduced pressure at 25 °C with
a rotary evaporator. The nanoparticles suspensions in water were stored in a
refrigerator at 4 °C. [66]
To promote the production of nanoparticles with desirable sizes for follicle
targeting, some alterations were introduced to the original method of
nanoprecipitation, according to three different techniques: agitation, sonication and
homogenization. In the first technique, the organic phase was added drop wise (at a
uniform rate) into the aqueous phase with stirring at 100 rpm and the solution
obtained was stirred overnight at the same velocity. For sonication, after the addition
of the organic phase to the aqueous phase, the preparation was submitted to an
ultrasound treatment. The reaction vessel was an open glass cell (diameter of 19 mm
and height 75 mm) which contained 15 mL of sample solution and its temperature was
maintained at 5 ± 1 °C. The probe was placed in the anti-nodal point (19 mm depth)
and the power delivery was controlled as percentage amplitude at 40%. Two times of
sonication were tested (15 and 18 min), with a pulsed duty cycle of 8 s on, 2 s off in
order to determinate which time promotes the production of nanoparticles with most
appropriates sizes attending to the objective of the particles. Finally, in
homogenization, the acetonic solution of PLA was added to aqueous phase and the
resultant solution was homogenized for 18 min, with a constant flux of 40 mL/min.
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3.2.1.1. Addition of a Non-Solvent to the Solvent Phase
Since the presence of a portion of a non-solvent for the polymer, in the
solvent phase, can improve the properties of the particles, the effect of different ratios
of ethanol and water were tested in the production of PLA nanoparticles [66]. Initially,
to evaluate the affinity of PLA to ethanol and water, the cloud points were determined
applying the titration technique. Acetonic solutions containing different
concentrations of PLA were slowly titrated with ethanol or water until the polymer
begins to precipitate, noted by the appearance of a distinct cloudiness – the cloud
point. The percentage of the non-solvents necessary to reach the cloud point is
considered the maximum fraction of non-solvent in the mixture with acetone to
continue to be complete dissolution of the polymer [78]. For a PLA concentration of
2% (w/w), the maximum proportion of ethanol in the mixture with acetone is 55% and
for water is just 10%. With the results of titrations, PLA nanoparticles were produced,
according to the techniques previously described, using mixtures of Acetone/Ethanol
(45/55, v/v) and Acetone/Water (90/10, v/v) to dissolve the polymer.
3.2.1.2. Effect of the Concentration of Pluronic F68
The effect of the concentration of the surfactant agent, in the properties of
the particles, it was also evaluated. Thus, solutions of 2% (w/w) of PLA were prepared
and added to aqueous phases containing different amounts of Pluronic F68; the
concentration of the surfactant agent in the resultant solutions was 0.6% (w/w), 1%
(w/w), 1,5% (w/w) and 2% (w/w).
3.2.2. Yield of Nanoparticles
Not all of the polymer used in the preparations (mtotal) can form nanoparticles
since there is some starting-material that aggregates during the nanoprecipitation
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process (magg). Thus, the yield of nanoparticles can be determined according to the
Equation 3-1.
ܻ݅݁ ݈݀ ݋݂ ܰ ܽ݊݋݌ܽݎ݅ݐ݈ܿ ݁ݏ(%) = ݉ ௧௢௧௔௟− ݉ ௔௚௚
݉ ௧௢௧௔௟
× 100
Equation 3-1: Determination of efficiency of nanoparticles formation.
For the calculation of the mass of aggregates, it was considered all of the
polymeric fractions which were not nanoparticles - polymer stuck to the magnetic
stirrer, to the flask or to other recipients which contained the formulations (polymer
losses) and particles in the range of micrometers or above [68].
In the quantification of polymer losses, all the materials that contained or
were in contact with formulations were washed with acetone to dissolve the polymer
stuck to them and this solution was further recovered. Then, excess of methanol was
added to precipitate the polymer and the solvents were removed with rotary
evaporator. The recovered polymer was dried and weighted [68].
To determine the mass of produced particles that lies above the range of
nano sizes, the formulations were passed through a GF/C glass microfiber filter with
pore size of 1.2 µm (Whatman, Maidstone, UK). The recovered polymer in the filters
was dried and weighted [58].
3.2.2.1. Effect of Ethanol in the Yield of Nanoparticles
To evaluate the effect of ethanol, used together with acetone to dissolve the
polymer, in the yield of nanoparticles, the particles were prepared by using different
ratios of Acetone/Ethanol – 55/45, 50/50 and 45/55%. The formulations were
prepared as previously described and the yield was determined following the
methodology described above. Since the fraction of ethanol could also promotes
alterations on the nanoparticles properties, the size, Polydispersity Index (PDI) and
zeta (ζ)-potential of the produced particles were also investigated.
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3.2.3. Characterization of the Particles
The size, PDI and ζ -potential of nanoparticles were determined using
ZetaSizer Nano ZS equipment; all the measurements were performed at 25 ± 1 °C. Each
value is the average of at least three independent measurements and the results were
expressed as mean value ± standard deviation.
The morphology of the particles was also assessed, using Scanning
Transmission Electron Microscopy (STEM).
3.2.3.1. Particle Size and Size Distribution Measurements
The size and PDI of the particles produced above were determined by Photon
Correlation Spectroscopy (PCS). This method measures the Brownian motion of the
particles, which allows the determination of its diffusion coefficient. The Stokes -
Einstein equation (Equation 3-2) relates the diffusion coefficient (D) with the diameter
of the particles (d), also using the values of Boltzman constant (K) and temperature in
Kelvin (T). PDI is indicative of the heterogeneity of the sample size and its values
ranges between 0.0 and 1.0 – the higher the PDI, the greater the heterogeneity of the
sample.
D = KT
3πd
Equation 3-2: Equation of Stokes-Einstein used to determinate the diameter of the
particles.
3.2.3.2. Analysis of the Zeta-Potential
Zeta-Potential is a characteristic parameter of the nanoparticles charge, since
the surface potential cannot be directly measured. For its determination, the particles
Materials and Methods
43
are submitted to a weak electric field and their electrophoretic mobility is determined
by laser Doppler anemometry (LDA). With Henry equation (Equation 3-3), it is possible
to relate the electrophoretic mobility (µe) with Zeta-Potential (ζ-potential). The values 
of dielectric constant (ε), viscosity of the medium (η) and f(Ka) - role of Henry - are also 
present in the equation.
μ௘ = 2ߝζ − potentialf(Ka)3η
Equation 3-3: Equation of Henry used to determinate the electrophoretic mobility
of the particles.
3.2.3.3. Morphology of Nanoparticles
The shape and surface morphology of nanoparticles were analyzed by STEM,
which allows the direct observation of nanoparticles suspended in a liquid layer. The
solution containing nanoparticles were diluted and placed onto copper grids with
carbon film 400 meshes, 3 mm diameter. Then, the observations were performed at
15 kV using a NOVA Nano SEM 200 FEI [20].
3.2.4. Preparation of Dye-loaded Nanoparticles
Fluorescent particles containing Nile Red (NR) or Fluorescein 5(6)-
isothiocyanate (FITC) were prepared – these fluorochromes were used as models of
lipophilic (NR) and hydrophilic (FITC) compounds. NR was chosen because of its
emission in the red region of the light spectrum, where skin has a low auto-
fluorescence. FITC was chosen because of its excellent fluorescence quantum yield.
The particles were obtained employing the same techniques used to produce
empty particles, with the dye being dissolved along with the polymer. The solution
containing PLA and the dye was added to the aqueous phase and the concentration of
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dye in the resultant solution was 0.3% (w/v). Then, the solvents were evaporated and
the size, PDI and ζ-potential of the particles were measured. During the entire 
experimental procedure, the solutions were protected from the light [45].
3.2.4.1. Determination of Entrapment Efficiency
The amount of the compounds, which were not entrapped in the
nanoparticles, was determined with Ultraviolet (UV)-Spectrophotometry. Two
fractions were considered for this quantification: the amount of dye entrapped in the
aggregates of polymer that remains stuck to the material (see section about “Yield of
Nanoparticles”) and the dye that was not entrapped inside nanoparticles and
remained free in the formulation.
For the quantification of the dye in the aggregates, after the preparation of
nanoparticles, all the materials that contained or were in contact with formulations
were washed with acetone to dissolve the polymer and the dye stuck to them. An
aliquot of this solution was diluted with the adequate solvent and the ﬂuorescence 
intensity was measured spectrophotometrically. For Nile Red, the dilution was made in
acetone and measurements were performed with an excitation wavelength of 536 nm
and emission wavelength of 608 nm [79]. For FITC, the dilution was made in water and
the wavelengths of excitation and emission were 495 nm and 525 nm, respectively.
The amount of free dye was achieved with dialysis. The formulations with
particles containing the dyes were placed in dialysis membranes (molecular weight
cutoff 12400 Da) and dialyzed against distillated water for 24h. After that, the dialysis
medium was changed two times at each 2h. Aliquots of the dialysis mediums were
collected and diluted in distillated water and the fluorescence of the samples was
measured; for Nile Red the excitation and emission were performed at 591 nm and
657 nm, respectively [79]. However, for FITC it was used the same wavelengths
previously mentioned for the quantification of the dye in the aggregates.
As empty PLA-NPs and Pluronic F68 showed no fluorescence for the
wavelengths used above, the amount of the dyes in both fractions was determined
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comparing the fluorescence intensity of the unknown samples with the standard
samples (calibration curves previously constructed). Then, the Entrapment Efficiency
was assessed using the Equation 3-4, presented below, where minitial is the mass of dye
used to the production of nanoparticles and mlosses is the total amount of dye
recovered from the polymer aggregates and dialysis.
ܧ݊ݐܽݎ ݌݉ ݁݊ ݐܧ݂݂ ݅ܿ ݅݁ ݊ ܿݕ(%) = ݉௜௡௜௧௜௔௟− ݉ ௟௢௦௦௘௦
݉ ௜௡௜௧௜௔௟
× 100
Equation 3-4: Entrapment efficiency of compounds in the PLA nanoparticles.
Along with the previously quantification of total dye encapsulated in
nanoparticles (mencapsulated dye), it was also determined the amount of PLA that form
particles (mnanoparticles), using the method described in the section about “Yield of
Nanoparticles”. Thus, with the Equation 3-5, it was possible to obtain the loading
efficiency, which corresponds to the amount of dye per milligram of nanoparticles.
For the entrapment efficiency and loading efficiency, the measurements were
made at least three times and the results were expressed as mean value ± standard
deviation.
ܮ݋ܽ ݀݅݊ ݃ܧ݂݂ ݅ܿ ݅݁ ݊ ܿݕ(%) = ݉ ௘௡௖௔௣௦௨௟௔௧௘ௗௗ௬௘
݉ ௡௔௡௢௣௔௥௧௜௖௟௘௦
× 100
Equation 3-5: Loading efficiency of the dyes in the PLA nanoparticles.
3.2.4.2. In vitro Release Profile and Dye Release Kinetics
In vitro release behavior of Nile Red and FITC from the PLA nanoparticles was
studied with a two-phase system (hydrophilic/lipophilic) using water and isopropyl
myristate (IPM); IPM was used due to its composition, which can mimic the lipophilic
structure of the stratum corneum [45]. For that, 1 mL of aqueous suspension of
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nanoparticles (containing either Nile Red or FITC) was added to the same volume of
IPM. For particles containing NR, the system was constantly stirred (50 rpm) at 37 °C,
and small aliquots (10 µL) of the lipophilic phase (receptor medium) were collected
and replaced with the same volume of IPM at fixed time points (0, 1, 2, 4, 6, 8, 12 and
24h). The aliquots were restored with the lipophilic solvent and the fluorescence
intensity was measured by UV-Spectrophotometry using 520 nm and 570 nm as
excitation and emission wavelengths, respectively [33]. In the case of particles loaded
with FITC, the release tests were also performed at 37 ˚C, with stirring rate of 50 rpm. 
At the same fixed time points used for Nile Red, the hydrophilic phase was collected
and centrifuged at 3000 g for 15 min, to separate nanoparticles from the free dye.
Then, an aliquot of the supernatant was withdrawn, restored with distillated water and
the fluorescence was measured by UV-Spectrophotometry; excitation and emission
wavelengths were 495 and 525 nm, respectively. Finally, the supernatant was
discharged and the nanoparticles were ressuspendend with 1 mL of water; the particle
suspension was added again to the lipophilic phase and incubated at the same
conditions [80]. The concentration of the released dyes was determined comparing the
fluorescence intensity of unknown samples to that of standard samples (calibration
curves previously constructed), in order to establish the release rates of Nile Red and
FITC from nanoparticles. The in vitro release study of the fluorochromes from
nanoparticles was carried out in triplicate.
With the release rates of fluorochromes, it was possible to achieve the release
behavior of the dyes from the PLA nanoparticles. Thus, the release data was fitting to
the empirical relationship given by Ritger-Peppas equation (Equation 3-6) [20].
ܯ௧
ܯஶ
= ݇× ݐ௡
Equation 3-6: Ritger-Peppas equation.
The n value on the equation is the diffusion exponent characteristic of the
release mechanism and it is given by the relation between the fraction of drug
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released at time t (Mt/M∞); t is the release time and k is the kinetic constant. To
determine the value of n, the Equation of Ritger-Peppas is transformed (Equation 3-7)
and n is the slope value of the plot of log (% release) versus log t [20].
log(% released) = log൬M୘Mஶ ൰= log k + n × log t
Equation 3-7: Ritger-Peppas modified equation.
3.2.5. In vitro Follicular Penetration Studies
In vitro follicular penetration studies of topically applied PLA particles
(obtained with agitation and ultrasound, containing hydrophilic or lipophilic dyes) were
carried out using Franz diffusion cells (Figure 3-1). These diffusion cells consist of a
donor compartment and a receptor compartment among which a membrane
(biological or artificial) is mounted; an O-Ring is used to position the membrane. The
two cell compartments are hold together with a clamp and the temperature in the
receptor chamber is controlled by a circulating water bath. In this work, the receptor
compartment was filled with 5 mL of phosphate buffered saline (PBS, pH 7.4),
thermostatically maintained at 37 °C, that was continuously stirred at 600 rpm with a
magnetic bar. Both compartments were sealed with aluminum foil to prevent
evaporation of the solutions.
3.4.5.1. Preparation of the Skin
In this study, pig skin was used due to its resemblance with human skin
regards to permeability [81]. Before experiments with skin, subcutaneous fat was
carefully removed using forceps and a scalpel, the skin was cut into individuals sections
of appropriate size and the surface was cleaned with PBS (pH 7.4). Finally, the skin was
inspected macroscopically and microscopically (using light microscopy after staining
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with haematoxilin and eosin) for tissue damage. Immediately after its preparation, the
skin was used.
Figure 3-1: Sketch of
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3.4.5.3. Cryosections and Fluorescence Microscopy
The penetration of PLA-NPs into hair follicles was investigated on skin
cryosections with fluorescence microscopy. After skin incubation with nanoparticles
containing fluorescent dyes, the skin samples were embedded in cryocompound Neg-
50 Frozen Section Medium (Thermo Scientific Inc., Bremen, Germany), frozen in liquid
nitrogen and finally they were cut vertically with fresh blades into 20 µm thickness
cryosections using a cryostat. Hair follicles from skin areas treated with particle-
containing formulations were obtained; to avoid counting the same hair follicle twice,
once obtained a central section of a hair follicle, the next 2-5 sections were excluded.
The cryosections were mounted on glass slides and visualized by bright field and
fluorescence microscopy in a microscope equipped with a filter for FITC and Nile Red.
By superposition of the images, the maximal depth reached by nanoparticles was
classified accordingly to Figure 3-2.
Figure 3-2: Depth of penetration of PLA nanopa
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4.1. Preparation of PLA Nanoparticles
Firstly, nanoprecipitation method was used to produce PLA nanoparticles.
Since these particles are intended for hair follicle targeting, their size should be as
small as possible, assuring a deeply penetration into the follicles, but not less than
100 nm to avoid their translocation into the viable epidermis of intact skin [45].
The produced particles should be stable and ζ-potential (measure of the 
surface charge of the particles) was used to predict their stability; as the ζ-potential 
increases, the repulsive interactions will be larger (preventing aggregation), increasing
the stability of the nanoparticles dispersion. A colloidal dispersion of charged particles
only stabilized by electrostatic repulsion is considered stable when Zeta-Potential have
a minimum value of ± 30 mV [69].
4.1.1. Comparison of Preparation Techniques
In order to obtain smaller particles than nanoprecipitation usually provides,
some alterations to the standard method were introduced, accordingly to three
different techniques: agitation, sonication and homogenization.
Regarding to sonication, it is known that the depth of probe tip from the base
of the vessel, the power input and the duration of treatment can influence the
ultrasound conditions imposed in the solution, affecting the size range and ζ-potential 
of the particles obtained. Thus, based on the results obtained by Silva et al. (2010), the
nanoparticles were produced at 19 mm of depth (anti-nodal point; λ/4), where the 
amplitude of the wave is a maximum, and 40% of power input. Using these conditions,
the authors reported that highest values of energy input are achieved, the cavitation
phenomenon is more pronounced promoting a higher hydroxyl radicals (•OH)
formation, greater shear forces are exerted and a higher mixing of the solution is
obtained, allowing the formation of particles with the lowest sizes and the highest
homogeneity [82]. Concerning to the duration of the treatment, using the mentioned
conditions, two times (15 and 18 min) were tested in order to understand its effect on
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the properties of PLA nanoparticles. In Figure 4-1, it can be seen that particles
obtained with 18 min of sonication were substantially smaller and more homogeneous
than those obtained with 15 min of treatment. It is proposed that, for 18 min of
sonication, the amount of energy supplied to the system was greater, increasing the
shear stress, which caused a more efficient particle breakdown resulting in a decrease
of the mean diameter and PDI of particles [39]. About the measurements of ζ-
potential, no significant differences were found amongst the tested times (data not
shown), showing that the time of sonication did not change the stability of particles
produced.
Figure 4-1: Mean size and size distribution (PDI) of PLA nanoparticles, obtained
after a sonication treatment of 15 and 18 minutes.
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particles with sonication and homogenization. The size, PDI and ζ-potential of particles 
obtained with the different techniques are shown in Table 4-1.
Table 4-1: Effect of the employed techniques on the properties of PLA
nanoparticles, obtained by nanoprecipitation.
Z-average
(nm) ± SD
Polydispersity
Index ± SD
Zeta-Potential
(mV) ± SD
Agitation 161.4 ± 0.4 0.047 ± 0.003 -20.0 ± 0.1
Sonication 172.6 ± 2.1 0.109 ± 0.007 -19.6 ± 0.2
Homogenization 640.2 ± 71.3 0.146 ± 0.015 -20.0 ± 1.4
As expected, surface charge of nanoparticles was negative. It is known that
PLA chains have carboxyl groups at their extremity and, when they aggregate to form
nanoparticles, these groups tends to be located in the aqueous environment, creating
a negative surface charge [83]. Attending to the values of ζ-potential, as they were 
higher than -30 mV, nanoparticle suspensions seemed to have only moderated
stability. However, it has to be notice that a non-ionic surfactant (Pluronic F68) was
used and therefore, the effect of steric stabilization (surfactants or other molecules at
the particle surface) must be taken into account [84]. Once the adsorbed layer of
Pluronic F68 can partially masks the carboxyl groups at the surface of nanoparticles
(due to the shift in the shear plane of the particles), it will leads to a decrease in the
surface charge (absolute value) of nanoparticles [83]. Thus, the ζ-potential obtained is 
sufficient to keep the system stable under the steric stabilization offered by Pluronic
F68 chains. Finally, as the differences on ζ-potential were neglectable, it could be 
assumed that all the techniques produced particles with similar stability.
While the duration of treatment was the same, particles produced with
homogenization had larger mean diameter than those produced by sonication; the
Preparation of Particles for Cosmetic Applications in Human Hair
56
population of particles obtained with the homogenizer was also more heterogeneous
than the population obtained with the sonicator (Table 4-1). Since the most direct
influence on the shear stress is exercised by the energy density (external energy
applied per unit total volume), and the magnitude of shear stress is inversely
correlated to the size of particles, it is possible that energy provided to solution by
sonication was higher, explaining the improved properties of particles obtained with
sonochemical treatment [39]. Moreover, the production of free radicals in solution is
much more pronounced with ultrasound than with the homogenizer. This may also
have been responsible for the results obtained as the interference of these free
radicals with the nanoparticles is more extensive in sonication, helping in the reduction
of their size [82, 85].
Despite the particles produced with ultrasound were smaller than those
produced with homogenization, NPs produced with agitation were even smaller and
more homogeneous than particles produced by sonication. The dropwise addition
used in this technique can be the major responsible for the particle size obtained. It is
known that the formation of NPs via nanoprecipitation is caused by the nucleation of
small aggregates of macromolecules followed by the aggregation of these nuclei [86].
As dropwise addition can induce a better spread of the organic phase into the aqueous
phase, it is possible that aggregates formed were smaller than those obtained with
sonication and homogenization in which the PLA solution was added to the outer
phase, all at once. Consequently, smaller aggregates of macromolecules conducted to
the formation of smaller particles. Another explanation for the results obtained can be
attributed to the rate of diffusion of the solvent into the aqueous phase; as the ratio
aqueous phase to organic phase increases, there is a faster diffusion of the solvent into
the outer phase and smaller particles are produced [39, 87]. Thus, in agitation, for
every drop added to aqueous solution, the ratio aqueous to organic phase was much
more higher than the ratio obtained for the addition of the organic solution all at once
(sonication and homogenization), leading to a faster diffusion of the solvent from each
droplet and consequently to the formation of smaller particles. The further overnight
agitation provided enough mechanical force to the solution to decrease even more the
size of particles, also promoting a greater homogeneity.
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4.1.2. Influence of the Solvent Phase
According to Fessi et al. (1986), the addition of a portion of a non-solvent to
the solvent phase can be advantageous for the production of smaller nanoparticles by
nanoprecipitation [66]. Thus, in this experiment, it was tested the influence of two
binary mixtures - Acetone/Water (90/10, v/v) and Acetone/Ethanol (45/55, v/v) - on
the properties of PLA nanoparticles, prepared with agitation and sonication. As it can
be seen in Table 4-2, the size of particles was markedly affected by the nature of the
solvent, with both techniques showing an increase on the mean diameter of
nanoparticles in the following order: Acetone/Ethanol < Acetone < Acetone/Water.
Table 4-2: Effect of the solvent phase on the properties of PLA nanoparticles,
prepared with agitation and sonication.
Solvent Phase
Z-average
(nm) ± SD
Polydispersity
Index ± SD
Zeta-Potential
(mV) ± SD
Agitation Acetone 161.4 ± 0.4 0.047 ± 0.003 -20.0 ± 0.1
Acetone/Water 170.2 ± 4.3 0.081 ± 0.011 -20.9 ± 2.0
Acetone/Ethanol 146.1 ± 1.6 0.078 ± 0.007 -21.5 ± 1.3
Sonication Acetone 172.6 ± 2.1 0.109 ± 0.007 -19.6 ± 0.2
Acetone/Water 196.4 ± 14.0 0.126 ± 0.019 -22.1 ± 0.3
Acetone/Ethanol 146. 5 ± 8.1 0.123 ± 0.015 -22.9 ± 3.4
To some extent, the results obtained can be explained attending to the
interactions organic phase-aqueous phase in the formulation. When the polymer-
containing solution is dispensed into the aqueous phase, the higher the affinity of the
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solvent to water, the faster its diffusion and particles with smaller sizes are formed
[88-90]. The affinity of a solvent to water is given by its polarity which in turn is related
to its dielectric constant (higher dielectric constant corresponds to higher polarity).
The dielectric constant of acetone, water and ethanol are mentioned on the literature
as 21, 80 and 30, respectively. On the other hand, the dielectric constants of the
mixtures used in this work were determined theoretically from the Equation 4-1.
ܧ = %ܣܿ݁ ݐ݋݊ ݁ܧ(ܣ) + %ܤܧ(ܤ)100
E = Dielectric constant of the mixture
E(A) = Dielectric constant of Acetone
E(B) = Dielectric constant of Water or Ethanol
%Acetone = Content of Acetone in mixture (%)
%B = Content of Water or Ethanol in mixture (%)
Equation 4-1: Theoretical determination of dielectric constant of the mixtures of
solvents.
The dielectric constants for the mixtures Acetone/Water (90/10, v/v) and
Acetone/Ethanol (45/55, v/v) are 26.9 and 25.95, respectively [90]. Attending to the
values obtained, the dielectric constants can explain why nanoparticles obtained with
a mixture of Acetone/Ethanol (45/55, v/v) are smaller than those obtained with
Acetone. On the contrary, as the mixture of Acetone/Water (90/10, v/v) has the
highest dielectric constant amongst the three tested solvent phases, the particles
produced should have the smallest sizes but the results obtained showed the opposite.
Thus, to completely understand these results, the affinity of PLA to the solvent
(polymer-solvent interactions) must also be taken into account.
As the affinity of PLA to the solvent increases, the polymer can be better
dispersed, leading to chains more detangled from one another and an extensively
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solvation occur. Contrarily, when the affinity of the polymer to the solvent decreases,
the chains become more shrunken, forming a solution with increased intrinsic viscosity
that avoids an efficient diffusion of the organic phase; since there is no separation of
the polymer chains, they have tendency to overlap. Due to the limited solvation, when
the water penetrates in regions between the chains, the isolation of larger cluster
occurs and particles with larger sizes are obtained [87, 91]. For sonication, an increase
of the viscous forces in solution will also opposes to the shear stress produced by
ultrasound, decreasing the net shear stress available for particle breakdown, producing
particles with increased size [39]. Since acetone is a solvent for PLA, the polymer has a
great affinity to it. Concerning to water and ethanol (both non solvent), the affinity
was determined experimentally; water showed less affinity for PLA than ethanol
because a lower percentage (10%) of water was necessary the reach the cloud point
(maximum fraction of non-solvent in the mixture with acetone to continue to be
complete dissolution of the polymer) when compared to ethanol (55%). Thus,
attending to the interactions polymer-solvent, it is now more acceptable that the
mixture Acetone/Water (90/10, v/v) had produced the particles with the larger sizes
for both techniques because, despite its diffusion rate was the faster, it was not
enough to counteract the negative effects of the increased viscosity of the system. On
the other hand, it is hypothesized that the decreased affinity of PLA to the mixture
Acetone/Ethanol (45/55, v/v) when compared to acetone was not enough to attenuate
the effect of its faster diffusion into the aqueous phase whereby, PLA-NPs produced
with this mixture had smaller sizes.
About the size distribution of nanoparticles, for both techniques, the
homogeneity (PDI) was slightly (not significant) increased in the following order:
Acetone < Acetone/Ethanol < Acetone/Water (Table 4-2). As it can be seen, there was
a correlation between the affinity of the solvent to the polymer and the polydispersity
index obtained, confirming once again that this parameter can be an important factor
related to the formation of nanoparticles, using the nanoprecipitation method.
Attending to ζ-potential (Table 4-2), for both techniques, the particles 
obtained with the different solvents were very similar regarding to the stability.
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4.1.3. Effect of the Surfactant Concentration
Nanoparticles produced by nanoprecipitation can generate colloidal stability
even without the presence of a surfactant. However, its utilization can be
advantageous to obtain particles with smaller sizes and PDI, as it will be adsorbed on
the surface of the nanoparticles, lowering their surface energy and hence reducing
coalescence and agglomeration promoted by the gradual increase in droplet viscosity
as the organic phase diffuses into the aqueous phase [66, 78, 83]. Consequently, in the
previous steps of this work, a 0.6 % (w/w) of Pluronic F68 was employed in the
formulations; even if this amount of stabilizer had been proved enough to obtain
adequate nanocarriers for follicular targeting, the concentration of surfactant in the
formulation was varied to analyze its effect on the properties of the particles and the
results are shown in Figure 4-2.
Figure 4-2: Effect of Pluronic F68 on the size and PDI of nanoparticles produced by
nanoprecipitation, using agitation and sonication.
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The results obtained in this study show that an increase in surfactant
concentration increased the size of nanoparticles; similar results have also been
reported in the literature [33, 90, 92, 93]. For polymeric surfactants, such as Pluronic
F68, an increase in their concentration is responsible for an enhancement of the
viscosity of the aqueous phase which can decreases the wavy movement and collision
of the particles, avoiding its aggregation and promoting the formation of particles with
smaller sizes [84]. However, as the viscosity of the aqueous phase increases, the
diffusion of the organic phase into the aqueous phase can be hindered and a reduction
in the net shear stress available for particle breakdown can occur, which promotes the
formation of larger droplets and consequently leads to an increase on the mean size of
particles (as observed in this work) [39, 90, 94].
Regarding to the polydispersity, there was a reduction on the PDI until 1.5%
(w/w) of Pluronic F68. It is hypothesized that as more surfactant molecules were
added to the solution, more stabilizer molecules overlaid the surface of particles,
reducing their surface tension and improving protection from coalescence promoting a
better homogeneity [78]. Above 1.5% of Pluronic F68, for sonication, the polydispersity
remained practically the same probably because the saturation of surfactant that is
packing at the surface of the particles was achieved and the stabilizer could no longer
provide improved homogeneity [90, 92]. On the other hand, for agitation, a 2% (w/w)
of Pluronic F68 increased the polydispersity of the solution possible due to the
predominance of the effect of the viscosity over the stabilizer effect of the surfactant.
The viscosity of the aqueous phase hindered an effective dispersion of the organic
solution and since the mechanical stirring provided by agitation was not enough to
counteract the effect of high viscosity, the organic phase was not well dispersed and
the particles formed had very different sizes (particle population became more
heterogeneous) [39, 84, 90, 94].
Attending to the stability, when agitation was used, ζ-potential changed 
scarcely with the increasing of Pluronic (0.6% (w/w): -21.1 ± 0.7 mV; 1% (w/w): -23.4 ±
0.3 mV; 1.5% (w/w): -18.6 ± 0.3 mV; 2% (w/w): -21.0 ± 0.6 mV). On the other hand,
with ultrasound, there was a marked decrease on the absolute value of ζ-potential as 
the concentration of surfactant increased (0.6% (w/w): -22.7 ± 2.4 mV; 1% (w/w): -20.8
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± 0.1 mV; 1.5% (w/w): -19.7 ± 0.2 mV; 2%(w/w): -15.9 ± 0.5 mV); nevertheless, this
tendency must not be assumed as a decreasing in the stability of the particles. It is
possible that ultrasound can promote a better adsorption of surfactant on the surface
of particles than agitation and, as more surfactant molecules were adsorbed to the
surface of particles, an increased screening of the carboxyl groups of PLA (responsible
for the negative charge of nanoparticles) occurred, promoting a decrease in the
particle charge.
4.2. Yield of Nanoparticles
The yield of nanoparticles is a decisive factor to evaluate the efficiency of a
preparation method, especially on large industrial scale [78]. Thus, in this part of the
work, the yield of nanoparticles was firstly determined for formulations prepared with
a mixture Acetone/Ethanol (45/55, v/v). Then, once ethanol can influence the
efficiency of nanoparticles formation (as reported by Jiang et al., 2003), the effect of
different volume fractions of this solvent in the organic phase were tested in order to
clarify its effects on the yield of PLA nanoparticles [78]. In Figure 4-3, for agitation and
sonication, the yields obtained are plotted against the volume fraction of ethanol in
the binary mixture. For all the tested fractions, the measurement of nanoparticles
yield, made on at least three different batches produced under identical conditions,
fell within a range of 10%, indicating a good reproducibility of the results.
Since the production of large polymeric aggregates, either dispersed in the
aqueous phase or adhered to the recipients, plays a key role on the yield of
nanoparticles, they will be used to explain the results obtained; as the amount of
aggregates that are not nanoparticles increases, the yield of nanoparticles decrease
[68]. Attending to the technique, in agitation, the dropwise addition combined with
continuous stirring promotes an efficient spread and a fast diffusion of the organic
phase into the aqueous phase, which led to the precipitation of PLA mostly in the form
of small nanoparticles that remained in suspension [18]. As this technique fails to form
large aggregates, this is probably the reason why a low percentage of polymer stuck to
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the recipients was recovered. In contrast, in sonication treatment, the PLA solution
was added to the aqueous phase all at once, without mixing. When the two phases
became in contact, since the molecules of PLA in the aqueous phase are not as well
dispersed as in agitation and the diffusion is slower, it is hypothesized that more
polymeric molecules can agglomerate to form large aggregates that due to its
dimensions settle to the bottom of the containers; the results obtained confirmed this
assumption. Relating to the aggregates dispersed in solution, as previously reported,
agitation usually produce a population of nanoparticles more homogeneous than
sonication; thence, for sonication, it is most likely to find a larger amount of
nanoparticles that deviates from the average size and are above 1.2 µm. Consequently,
this can explain why the percentage of polymeric agglomerates recovered after
filtration was higher for the nanoparticles suspensions produced by ultrasound. In
conclusion, as sonication produced higher percentage of large aggregates of PLA, the
percentage of nanoparticles effectively formed was lower than those obtained for
agitation, regardless of the fraction of ethanol.
Figure 4-3: Effect of the volume fraction of ethanol on the yield of nanoparticles,
prepared by nanoprecipitation.
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Despite the differences between agitation and sonication, the effect of
ethanol on the formation of nanoparticles was similar for both techniques: as the
fraction of ethanol increased, the yield of nanoparticles decreased (Figure 4-3). It is
known that an increase of the ethanol fraction increases the polarity of the binary
organic solvent (Equation 4-1), leading to a faster diffusion of the solvent phase into
the aqueous phase and consequent formation of smaller aggregates and formulations
with higher yields of nanoparticles. However, is also mentioned on the literature that,
as the diffusion process occurs faster, more polymer can immediately precipitates and
deposit before agglomeration into particles occurs [39, 88-90]. This is one of the
explanations for the increasing percentages of PLA agglomerates that were recovered
from the containers, as the volume fractions of ethanol increased. Secondly, as the
fraction of ethanol increases, the affinity of the polymer to the mixture decreases and
there is an increasing on the viscosity of the solvent. Further, an increasing on viscosity
of the organic phase will be responsible for the formation of higher amounts of larger
agglomerates that will increase the amount of polymer recovered from the containing
material or by filtration [87, 91].
In the first part of this work, it was proved that the polarity and viscosity of
the organic phase can influence the properties of the nanoparticles. Thus, once
different fractions of ethanol can promotes changes on these parameters of the
organic phase, the size and PDI of nanoparticles, prepared with the tested fractions,
were monitored - Figure 4-4. For sonication, when the fraction of ethanol increased,
the size and PDI decreased. Moreover, although the differences between 55% and 50%
were not significant, when the fraction of ethanol decreased to 45%, it was verified a
marked increase on the size of nanoparticles. This results are consistent with the
expected because, an increasing in the fraction of ethanol leads to a faster diffusion of
the organic phase, which in turn promotes the formation of smaller and more
homogeneous nanoparticles [88, 89, 115]. Despite the viscosity of the organic
increases for higher fractions of ethanol (which can increase the size of particle), the
viscous forces were probably not sufficient to counteract the effect of the ratio of
diffusion of the organic phase [87, 91]. Regarding to agitation, increasing the volume
fraction of ethanol from 50% to 55% also led to a slightly decrease on the mean size of
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the particles. However, with a 45% of ethanol on the binary mixture, instead of the
increasing on the particles size due to the slower diffusion of the solvent, it was
showed a considerable decrease on the mean diameter. This probably happened
because of the increased interactions polymer-organic phase that supplanted the
effect of the interactions organic phase-aqueous phase.
Figure 4-4: Effect of volume fraction of ethanol on the properties of PLA
nanoparticles, prepared with agitation and sonication.
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Finally, changes on ζ-potential of nanoparticles, as a result of the fraction of 
ethanol, were also investigated (Figure 4-4). As it can be seen, for sonication, the
stability of nanoparticles produced with increasing volume fractions of ethanol
remained practically unchanged since the values of ζ-potential were very similar. On 
the other hand, there was a decreasing (absolute value) on surface charge of particles
produced by agitation, as the volume fraction of ethanol decreased. For particles
produced with 45% of ethanol on the binary mixture, the value of ζ-potential was 
especially high (-15.2 ± 0.9 mV), which can be problematic as it can leads to
aggregation of nanoparticles during the storage.
4.3. Morphology of Nanoparticles
The characterization of particles surface is important in the context of
controlled release of active ingredients. Therefore, a NOVA Nano SEM 200 FEI was
used to visualize the nanoparticles previously prepared, using Acetone/Ethanol (50/50,
v/v) and a Pluronic F68 concentration of 0.6 % (w/w). Figure 4-5 shows the STEM
photographs obtained for PLA nanoparticles produced by nanoprecipitation, using
agitation and sonication. As the total amount of polymer was distributed
homogeneously through the solution during nanoprecipitation, the preferred shape of
the particles was spherical [85]. This morphology would offer the highest potential for
controlled release and protection of incorporated drugs as they provide minimum
contact with the aqueous environment as well as the longest diffusion pathways [84].
Even slightly agglomerated due to the high concentration on the sample,
nanoparticles seemed to have smooth surfaces and they showed clearly homogeneity.
However, as expected, the size distribution of NPs produced by agitation was narrow
when compared to those obtained by sonication.
Finally, regarding to the mean size of nanoparticles, the results obtained with
STEM are also in good agreement with the measurements made by PCS.
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Figure 4-6: Z-Average (nm), PDI and Zeta-Potential (mV) of PLA nanoparticles,
prepared with agitation and sonication, after the entrapment of Nile
Red and FITC.
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4.4.1. Entrapment Efficiency
The entrapment efficiency (ratio of quantity entrapped/adsorbed compound
in relation to the total amount of compound used) is an important factor for drug
delivery systems, once the release rate is usually dependent on the concentration of
the bioactive agent inside nanoparticles [95]. Thus, after the production of dye loaded
nanoparticles, the portion of fluorochromes not incorporated was quantified
spectrophotometrically, in order to achieve the entrapment efficiency of lipophilic and
hydrophilic molecules into PLA nanoparticles. For agitation and sonication, the
incorporation of model compounds proved to be efficient and the results obtained are
shown in Figure 4-7.
Figure 4-7: Entrapment efficiency of Nile Red and FITC into PLA nanoparticles,
produced with agitation and sonication.
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according to the diffusion rate of the organic phase into the aqueous phase. In
nanoprecipitation, it is known that the entrapment of compounds occurs as a result of
polymer precipitation, followed by solidification that leads to the formation of
nanoparticles [39]. In turn, the solidification of nanoparticles is related to the ratio of
diffusion of the organic phase. When the organic phase has low affinity to the
continuous phase, the diffusion is slow, hindering the solidification of nanoparticles.
Then, the complete portioning of the encapsulated compounds into the aqueous
phase is facilitated as the compounds have more time to diffuse into the aqueous
phase along with the organic phase [91]. Thus, as it was previously reported, when
compared to sonication the diffusion of the solvents is faster in agitation because of
dropwise addition; as the time to the compounds diffuse is lower, the amount of
encapsulated compound increases.
Regarding to the incorporation of FITC, the results obtained are surprising
taking into account that usually, nanoprecipitation is ineffective to encapsulate
hydrophilic compounds; due to its water-soluble nature, they rapid partioning from
the organic phase into the aqueous phase, leading to considerable losses in the
continuous phase [91]. However, probably due to the properties of the binary mixture,
it is possible that its diffusion rate and consequently solidification of the nanoparticles
was so fast that leakage of large amounts of FITC was avoided. Other properties of the
formulation, as viscosity of the organic phase and interactions polymer-drug, can also
helped to increase the diffusional resistance of FITC, since they were previously
involved on the achievement of high encapsulation efficiency of some molecules [39].
In addition to the entrapment efficiency, the loading efficiency was also
determined for both dyes. The drug loading provides a measure of the amount of
entrapped compound compared to the effective mass of nanoparticles [18]. Table 4-3
shows the differences in dye loading percentages. Since the formulation had similar
entrapment efficiencies but the yield of nanoparticles was higher for agitation, it is not
surprising that sonication had the highest loading efficiencies.
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Table 4-3: Loading efficiency of Nile Red and FITC into nanoparticles produced by
nanoprecipitation, using agitation and sonication.
Nile Red (%) ± SD FITC (%) ± SD
Agitation 0.0488 ± 0.0019 0.0508 ± 0.0004
Sonication 0.0608 ± 0.0058 0.0617 ± 0.0035
4.4.2. In vitro Release Profile
Nanoparticles prepared in this study aimed to be used for drug delivery and,
one important feature of these carriers is their release profile. Thus, the in vitro
release of Nile Red and FITC from PLA nanoparticles was studied in a biphasic system,
consisting in an organic lipophilic solvent (IPM) and an aqueous solution [45]. The
release studies were performed with this system because, firstly, PLA particles are
stable in aqueous suspensions and no release of the dyes is observed for particles kept
in water for long periods of time (the release is a slow process which occurs only upon
polymer hydrolysis and particle erosion). Furthermore, as these particles are intended
for topical application, IPM can mimics the lipophilic environment of the skin (chemical
structure of IPM resemble that of sebum components) and consequently, the
IPM/Water system can simulate the interface between the NPs aqueous suspension
and the sebum on the skin surface and in the hair follicle ducts [45]. For PLA
nanoparticles produced by the different techniques, the release profile of lipophilic
and hydrophilic models are shown in Figure 4-8. In all kinetic profiles, the in vitro
release exhibited a typical biphasic release phenomenon with an initial burst release in
the first four hours followed by a constant slow release over the remaining time.
Normally, the burst release is attributed to the fraction of the drug which is adsorbed
or weakly bound to the large surface area of NPs or entrapped in the matrix near to
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the surface of particles; slow and constant rate may be due to the diffusion of
compounds, as well as to the erosion of the polymeric matrix [62, 96].
A
B
Figure 4-8: In vitro release profile of A) Nile Red and B) FITC from PLA-NPs,
produced by nanoprecipitation with agitation and sonication.
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Regardless of their nature, the release of dyes was faster for PLA
nanoparticles produced with agitation. This can be due to the differences in drug
loading obtained for particles produced with the different techniques; for both dyes,
higher drug loading were achieved for particles produced by sonication (Table 4-3).
Several reports have showing that a compound can be slowly released in higher drug
contents because higher concentration leads to crystallization of compounds inside the
nanoparticles and the compound should dissolve first from the crystal and then
diffuses from the matrix (dissolution model), which reduces the compound release
rate [97, 98].
Attending to the differences in the release of different dyes, when particles
were placed in contact with IPM (t=0h), higher concentrations of FITC than Nile Red
were measured on the outside of nanoparticles. During the formation of nanoparticles,
FITC have a large tendency to rapidly partioning into the aqueous phase due to its
hydrophilic nature; usually, this leads to an inefficient entrapment of hydrophilic
compounds in the nanoparticles. However, in this study, it is hypothesized that binary
mixture used to dissolve the polymer and the dye promoted a solidification of the
particles so fast that losses of large amounts of the dye into the aqueous phase were
avoided. Thus, since the solidification of the particles is made from the periphery, it is
possible that high amounts of FITC that were trying to diffuse into the aqueous phase
were entrapped in the matrix of the nanoparticles near to the surface or they were just
adsorbed to the particle surface [69, 99]. Thus, when particles were added to IPM, due
to the destabilization of the particles, an immediately released of FITC that were
poorly entrapped in the particles occurred. As larger amounts of FITC than Nile Red
were poorly entrapped, this explained why the differences in the released compounds
at the first time point (0h). However, after the first time point, the lipophilic compound
showed a fast release from the nanoparticles. As it can be seen in Figure 4-9, after 24h,
Nile Red was completely released from particles produced by agitation and 85.64 ±
2.48% of the lipophilic dye was released from nanoparticles produced with sonication.
In turn, after 24h, only 50.80 ± 1.37 %, for particles produced by agitation, and 40.87 ±
2.36 %, for particles produced sonication, of the hydrophilic dye was released from PLA
nanoparticles. According to Rancan et al. (2009), upon contact with IPM, due to its low
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dielectric constant that drastically reduces the electrostatic forces responsible for the
stabilization of the colloid in the water phase, the PLA-NPs aggregates and irreversible
forms clusters at the interface between water and IPM. Then, the organic phase
penetrates within the PLA matrix [45]. For lipophilic compounds, such as Nile Red,
since it has affinity to the lipophilic solvent, the partion of the dye between the
lipophilic core of the particles and the lipophilic solvent occurred, leading to a rapidly
diffusion to the outside of particles [45]. The rapid dye leakage also contributed to the
destabilization of the particles that leads to the loss of the particulate state, which
promoted a further increase in the release of the loaded dye [100]. For particles
loaded with FITC, since this compound has poor solubility in the lipophilic solvent, a
slow dissolution rate was achieved leading to a slowly diffusion out of the particles.
This slow diffusion also had a stabilizing effect, and as a consequence of their higher
stability, there was no destabilization of particles, preventing a fast release and
resulting in prolonged fluorochrome release kinetics [70, 100].
Attending to the results obtained, and the results of other authors published
on the literature, for Nile Red it was hypothesized that release occurs as function of
diffusion and polymeric matrix degradation whereas for FITC, diffusion seems to
control the release of hydrophilic compounds. To confirm these predictions, the
empirical expression proposed by Ritger-Peppas was used to determine the
mechanism of drug release from polymeric nanoparticles produced in this work; this
equation is based on the Fickian diffusion equation [101]. For a sphere, a Fickian
diffusion of first order is observed when n has the limiting value of 0.43. Between 0.43
and 0.85, anomalous transport is observed coupling Fickian diffusion and polymer
degradation. Finally, for n=0.85, Case II transport (polymer relaxation/degradation)
occurs, leading to a zero-order release [84].
For PLA nanoparticles produced in this work, the n value obtained for the
tested dyes are shown in Table 4-4. For all the n values obtained, the correlation
coefficient “R2” was above the permissible range (0.95), further supporting the validity
of the results. As expected, for Nile Red, the drug transport mechanism obtained was
Non-Fickian diffusion or Anomalous, indicating the superposition of both extreme
phenomena: drug diffusion and macromolecular chain relaxation/degradation. For
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FITC, a Fickian diffusion of first order was achieved. Once again, these results indicate
that the type of compound entrapped in the nanoparticles influences the drug
transport mechanism.
Table 4-4: Dye release kinetic data obtained from fitting experimental release
data to Ritger-Peppas Equation, where “n” is the diffusion exponent
and R2 is the correlation coefficient.
Nile Red FITC
n R2 n R2
Agitation 0.847 0.993 0.209 0.959
Sonication 0.728 0.988 0.124 0.987
4.5. Follicular Penetration of PLA Nanoparticles
In order to confirm that nanoparticles obtained in this work can act as carriers
for drug delivery into the hair follicles, after application of PLA-NPs loaded with
lipophilic (Nile Red) and hydrophilic (FITC) fluorochromes on porcine skin, the samples
were sectioned and analyzed with fluorescence microscopy. The results obtained are
reported in Figure 4-9.
Attending to the images, it is possible to note the presence of the
fluorochromes inside the HFs, with fluorescence being detected along the entire length
of the follicular duct. On the other hand, no fluorescence is observed in the viable
epidermis. These results are in accordance with the findings of other authors, which
showed that the encapsulation of compounds inside nanoparticles prevents their
penetration on the skin through the transepidermal pathway, since NPs tends to
penetrate along the follicular ducts, being trapped inside these structures [45, 75,
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100]. Despite PLA-NPs did not reach the dermis, the results obtained shows that a
great amount of them accumulated in the stratum corneum, failing to penetrate into
the hair follicles. This behavior of NPs can be explained by the fact that no massage
was applied on the skin samples after contact with the formulation. In the literature is
reported that massage can simulate the hair movement that occurs physiologically
under in vivo conditions and, once the moving hairs acts as a geared pump pushing
particles deeply into the hair follicles, it enhances the penetration of NPs [37, 49].
Comparing the results obtained for NPs produced with agitation and
sonication, it is possible to note that the distribution of Nile Red along the follicular
duct was the same with the dye being detected at the deepest portion of the follicular
duct. This similar penetration profile was already expected since particles obtained
with both methodologies had comparable properties. However, the fluorescence was
less intense around the hair follicles of skin samples where PLA-NPs produced with
sonication were applied. As the concentration of particles in the formulation obtained
with ultrasound is lower than those obtained with agitation (as demonstrated
previously, formulation produced with ultrasound has lower yield), less particles were
available to penetrate the HFs, which can explain the difference in the results
obtained.
Finally, and contrary to the expected, FITC loaded PLA-NPs did not show a
deeper penetration when compared to particles loaded with Nile Red. As seen before,
since FITC has less affinity for lipophilic mediums (e.g., skin or sebum inside the hair
follicles), it diffuses slowly out of the particles, promoting a stabilizing effect that
enhances the penetration of these particles [100]. In turn, after the entrance of Nile
Red loaded NPs into the follicular ducts, a destabilization of the particles due to the
contact with the sebum and a fast release of the entrapped compound occur.
Consequently, the destabilized particles tend to accumulate in the upper part of the
follicular duct. Since this study did not allow to determine unequivocally that
fluorescence in the follicles was due to the particles with the dyes entrapped, it is
possible that released Nile Red had diffuse alone via the sebum to the deepest part of
the HFs and the fluorescence detected was due to the dye itself and not because of the
accumulation of particles at this level [45, 100].
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Figure 4-9: Fluorescence microscopy images (x5 magnification) of porcine skin
cryosections, after incubation with dye loaded PLA-NPs.
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In this study, the use of agitation, sonication or homogenization along with
the standard nanoprecipitation method allowed the successful preparation of PLA
particles in the range of nanometers. Using acetone as the solvent phase, agitation
proved to be the most suited technique to obtain carriers for follicular targeting since
it produced the smallest particles with the narrowest size distribution without the use
of higher energy apparatus (making it easier to scale-up). Nevertheless, since the mean
size of particles obtained with agitation and sonication was not so different, the
employment of ultrasound was also considered because it allows the preparation of
PLA-NPs much faster than agitation (18 min instead of one night). Furthermore, it is
well reported in literature the ability of sonication, compared with other techniques,
to achieve high drug loadings in the emulsification-solvent evaporation method [39]. If
in the progress of this work, the same ability could be proved for nanoprecipitation,
the use of ultrasound could become very competitive with mechanical stirring for the
production of drug loaded PLA-NPs.
As expected, the choice of a good solvent phase is crucial for the quality of
PLA nanoparticles produced by nanoprecipitation. Particularly, a fraction of a suitable
non-solvent (chosen on the basis of its polarity and upon the affinity of polymer to it)
in the solvent phase can favor the elaboration of particles with smaller sizes as seen for
the mixture Acetone/Ethanol. It is important to note that, despite the variations
obtained with other organic phases, no significant differences were found on the mean
size of particles produced with agitation and sonication when the mixture
Acetone/Ethanol was employed. Conversely, increasing the amount of Pluronic F68
does not decrease the size of PLA nanoparticles and the minimal tested concentration -
0.6% (w/w) - produced the smallest particles. In turn, particles with higher
homogeneity were obtained until a maximum of 1.5% (w/w) of surfactant. However,
the choice of the best concentration for the production of nanoparticles was made
attending to the concentration that provided the smaller sizes and not the lower
polydispersity. This occurred because, for 0.6% (w/w) of Pluronic F68, the
homogeneity of solutions was already adequate and it is known that as the
concentration of stabilizer increases, the drug incorporation can be drastically reduced
due to the interaction between drug and stabilizer [69, 92].
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In terms of the nanoparticles formation, higher yields can be obtained using
agitation instead of sonication. Also, as the volume fraction of ethanol in the solvent
phase increases, the yield of nanoparticles decreases. Nevertheless, the lowest ethanol
fraction (45%) promoted negative changes on the properties of nanoparticles; for
sonication led to an increase on the mean diameter of particles, whereas for agitation
the stability was compromised. Once the size, PDI and ζ-potential of particles produced 
with the other two tested fraction of ethanol (50% and 55%) do not had noteworthy
differences and 50% promoted a yield of nanoparticles closer to that obtained with
45%, Acetone/Ethanol (50/50, v/v) was assumed as the optimal mixture for the
production of PLA nanoparticles.
Taking into account the desired properties of particles for follicular targeting, as
well as the yield necessary for the commercial viability of a formulation, as intended,
at the end of the first part of this work, suitable formulations for the production of
PLA-NPs by nanoprecipitation were obtained. In the future, an upgrading in the
production must be conducted in order to understand if properties of nanoparticles
are not severely affected by the transition from laboratory to large-scale production.
Despite being produced from a material that is biocompatible, since the produced PLA
nanoparticles are intended for cosmetic applications in humans, an evaluation of its
cytotoxicity is also one of the next steps of this project.
The two methodologies for nanoprecipitation (using agitation and sonication),
presented in this work, demonstrates the ability to efficiently entrap lipophilic
compounds (Nile Red), but most important, the results obtained reflect the
underexplored potential of the method to entrap compounds of hydrophilic nature
(FITC). Also, although the entrapment efficiency for both dyes was slightly lower for
sonication, the use of ultrasound systems promoted higher loading efficiencies
(amount of entrapped compound compared to the effective mass of nanoparticles),
confirming the expectations for this technique. For drug delivery, this is an advantage
since a successful NP system may be the one which has a high loading capacity,
reducing the quantity of the carrier required for administration [62]. Regarding to the
release from PLA-NPs, it was shown to be dependent upon the nature of the
encapsulated compound, as well as upon its loading into nanoparticles. Using lipophilic
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molecules, the release is faster when compared to the hydrophilic ones. For a given
compound, a faster release is achieved using NPs produced with agitation (lower dye
loading) and if it is necessary a slower release, the compounds can be incorporated in
particles produced with sonication (higher dye loading). As a future task, the
production of PLA-NPs loaded with other lipophilic and hydrophilic compounds
(namely, drugs for the treatment of hair follicle diseases/disorders) will be performed
to determine their entrapment efficiency as well as their in vitro release profile and
drug release kinetics, in order to validate the results obtained with the lipophilic (Nile
Red) and hydrophilic (FITC) model compounds used in this study.
After in vitro studies of follicular penetration, it was confirmed that PLA-NPs
produced with agitation or sonication are equally capable to enhance the transport
molecules into the HFs. Moreover, these nanocarriers also proved to be well suited for
the delivery of lipophilic and hydrophilic model compounds into HFs, with the
fluorochromes achieving a maximal depth classified as deep penetration (level of
functional structures as the hair bulb). While the doubts whether the detected
fluorescence inside the HFs is due to particles or from the free dye (after release from
PLA-NPs) remains, what it is important to note is that, using the particles produced in
this work, the dyes were effectively incorporated into the HFs. After these preliminary
results, other experiments of follicular penetration will be performed with
formulations containing the same concentration of PLA-NPs (avoiding some defaults of
the experimental design used) and applying massage to the skin samples in order to
better simulate the in vivo conditions imposed by the HFs for the penetration of
topically applied nanoparticles.
Gathering all the results obtained, PLA-NPs produced in this work represent
ideal candidates for the encapsulation of different drugs that needed to be delivery
into the HFs. Then, these NPs may be used in cosmetic applications to enhance the
treatment of many hair follicles associated disorders/diseases.
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